The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 32, Issue 8, Pages 1625-1631
Publisher
Wiley
Online
2017-05-05
DOI
10.1002/jbmr.3163
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling
- (2016) Gary Hattersley et al. ENDOCRINOLOGY
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis
- (2015) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FRAX and the effect of teriparatide on vertebral and non-vertebral fracture
- (2015) N. C. Harvey et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX
- (2015) N. C. Harvey et al. OSTEOPOROSIS INTERNATIONAL
- Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures
- (2013) H. Johansson et al. OSTEOPOROSIS INTERNATIONAL
- Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
- (2012) Eugene V McCloskey et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: The fracture intervention trial
- (2012) Meghan G Donaldson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study
- (2011) S. L. Silverman et al. OSTEOPOROSIS INTERNATIONAL
- A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX®
- (2010) John A. Kanis et al. BONE
- Vertebral fracture assessment using a semiquantitative technique
- (2010) Harry K. Genant et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®
- (2009) John A. Kanis et al. BONE
- The potential impact of new National Osteoporosis Foundation guidance on treatment patterns
- (2009) B. Dawson-Hughes et al. OSTEOPOROSIS INTERNATIONAL
- Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study
- (2008) E. V. McCloskey et al. OSTEOPOROSIS INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now